Orphan G protein receptor GPR55 as an emerging target in cancer therapy and management

Dinorah Leyva-Illades; Sharon Demorrow

doi:10.2147/CMAR.S35175

Orphan G protein receptor GPR55 as an emerging target in cancer therapy and management

Cancer Manag Res. 2013 Jul 1:5:147-55. doi: 10.2147/CMAR.S35175. Print 2013.

Authors

Dinorah Leyva-Illades¹, Sharon Demorrow

Affiliation

¹ Digestive Disease Research Center, Scott and White Hospital, Temple, TX, USA ; Department of Internal MedicineTexas A&M Health Science Center, Temple, TX, USA ; Research Service, Central Texas Veterans Health Care System, Temple, TX, USA.

Abstract

G protein-coupled receptors (GPCRs) modulate a vast array of cellular processes. The current review gives an overview of the general characteristics of GPCRs and their role in physiological conditions. In addition, it describes the current knowledge of the physiological and pathophysiological functions of GPR55, an orphan GPCR, and how it can be exploited as a therapeutic target to combat various cancers.

Keywords: GPCR; GPR55; cancer; endocannabinoids.

Abstract

Grants and funding